Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Sunday, April 6th, 2025

Japfa Ltd 9M2024 Financial Growth: 2457% Net Profit Surge Enhances Investment Appeal in Asia’s Protein Market

Financial Analysis for Japfa Ltd – 9M2024

Business Description

Japfa Ltd, a leading vertically integrated agri-food company headquartered in Singapore, focuses on the production and distribution of protein staples, particularly in emerging Asian markets. The company operates across multiple segments, including:

  • Poultry, Swine, and Aquaculture through PT Japfa Tbk in Indonesia and Animal Protein Other (APO) across Vietnam, India, Myanmar, and Bangladesh.
  • Feed Production and Distribution as a key contributor to Japfa’s profitability, particularly in Indonesia and Vietnam, providing a stable revenue base.
    Japfa’s business model integrates upstream (feed production and breeding), midstream (fattening farms), and downstream (processing and distribution), positioning itself as a low-cost provider in the protein market.

Industry Position and Market Share

Japfa holds a strong market position in Asia, ranking second in Indonesia and Vietnam’s poultry markets, with a growing presence in swine and aqua-feed segments in Vietnam and Indonesia. Its large-scale, cost-efficient operations allow Japfa to maintain competitiveness and buffer against economic fluctuations.

Revenue Streams and Customer Base

Japfa’s revenue streams are diversified across poultry, swine, and aquaculture, with significant contributions from animal feed. Key customer segments include wholesalers and retail distributors in emerging Asia, where protein consumption is steadily increasing.

Competitive Advantage

Japfa leverages a vertically integrated structure and economies of scale in feed production. Its established breeding and fattening operations, along with advanced biosecurity measures, support Japfa’s resilience against health risks (e.g., African Swine Fever in Vietnam) and help maintain steady production.


Financial Statement Analysis

1. Income Statement (9M2024 vs. 9M2023)

  • Revenue increased by 3.7% to USD 3.42 billion.
  • Operating Profit surged by 177.5% to USD 293 million, supported by improved profitability in Indonesia and Vietnam.
  • EBITDA grew 91.6% year-over-year, reaching USD 375.2 million.
  • Net Profit saw an exceptional increase, from USD 6 million to USD 153.4 million (2457.3%), attributed to lower feed costs and effective cost management.
  • Core PATMI without Forex turned positive at USD 90.5 million compared to a loss in 9M2023, indicating improved core profitability.
  • Dividend: A one-off interim dividend of 1.0 Singapore cent per share was declared, reflecting strong cash generation and performance.

2. Balance Sheet Highlights (as of 30 September 2024)

  • Total Assets rose 4% year-to-date to USD 3.20 billion.
  • Equity improved 15% to USD 1.37 billion, with the net asset value per share increasing from USD 0.38 to USD 0.43.
  • Debt reduced by 11% to USD 1.33 billion, leading to a healthier debt-to-equity ratio, demonstrating improved financial stability and decreased leverage.

3. Cash Flow Statement

  • Operating Cash Flow increased significantly, supported by higher profits.
  • Investing Cash Flow included USD 87 million for capital expenditure to support growth in animal protein operations, particularly in Indonesia and Vietnam.
  • Financing Cash Flow reflects the reduction in debt obligations, enhancing Japfa’s liquidity profile and positioning it for future growth.

Key Investment Considerations

Compelling Reasons to Invest

  1. Strong Revenue Growth and Profitability: The company’s revenue growth and marked improvement in operating profit reflect strong demand and effective cost management, especially in Indonesia and Vietnam.
    • Reason: These growth areas are central to Japfa’s profitability, underscoring its resilience against market challenges.
  2. Financial Stability and Reduced Leverage: The reduction in debt and improved equity position indicate Japfa’s financial discipline and enhanced balance sheet stability.
    • Reason: Lower leverage increases Japfa’s capacity to fund future growth initiatives and manage economic fluctuations.
  3. Consistent Dividends: Japfa’s declaration of a 1.0 Singapore cent interim dividend highlights confidence in its financial performance.
    • Reason: Dividends appeal to income-focused investors and underscore Japfa’s robust cash flow.

Concerns and Reasons Not to Invest

  1. Volatile Market Conditions and Cost Pressures: Geopolitical tensions and cost-of-living pressures may impact consumer demand and raw material costs.
    • Reason: Economic uncertainties could dampen Japfa’s profitability in key markets.
  2. Exposure to Health Risks in Livestock: Despite strong biosecurity, risks like African Swine Fever in Vietnam remain a threat.
    • Reason: Disease outbreaks could disrupt supply and impact Japfa’s swine operations.

Summary of Key Findings

  • Strengths: Revenue and profitability growth, financial stability, and improved leverage.
  • Risks: External economic uncertainties, exposure to livestock health risks.

Investor Recommendations

  • For Current Investors: Hold. Japfa’s strong fundamentals and improved financial health make it a stable investment, especially as it continues expanding in emerging markets.
  • For Prospective Investors: Buy cautiously. Japfa’s growth and dividend potential are attractive, but new investors should consider potential risks from economic and industry-specific factors.

Disclaimer

This analysis is based on Japfa’s unaudited financial results as of 30 September 2024 and is not a substitute for professional investment advice.

Lendlease Global Commercial REIT FY2024: Balancing Growth with Sustainability for Long-Term Value Creation”.

Summary of Key Facts in the Report: Report Date and Scope: The sustainability report was published on October 2, 2024, covering Lendlease Global Commercial REIT (LREIT) activities for the financial year 2024. The report...

GKE Corporation Expects Significant Profit Increase for 1HFY25, Boosted by Organic Growth and Asset Divestment

GKE Corporation Limited Reports Significant Net Profit Growth GKE Corporation Limited Reports Significant Net Profit Growth Business Description GKE Corporation Limited, registered in Singapore, operates as a diversified investment holding company. The Group has...

Sri Trang Agro-Industry’s Q3 2024 Financial Review: Independent Auditor’s Report

Sri Trang Agro-Industry Financial Analysis – Net Profit Growth/Decline Sri Trang Agro-Industry Financial Analysis – Net Profit Growth/Decline Business Description Sri Trang Agro-Industry Public Company Limited is a leading company engaged in the production...